EDRAMF
Edmond de Rothschild Asset Management (France) Portfolio holdings
AUM
$2.29B
This Quarter Return
+1.08%
1 Year Return
+15.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.71B
AUM Growth
–
Cap. Flow
+$3.57B
Cap. Flow
% of AUM
96.33%
Top 10 Holdings %
Top 10 Hldgs %
26.37%
Holding
208
New
184
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Citigroup
C
|
$148M |
| 2 |
Merck
MRK
|
$112M |
| 3 |
MetLife
MET
|
$105M |
| 4 |
JPMorgan Chase
JPM
|
$103M |
| 5 |
UBS Group
UBS
|
$101M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 23.67% |
| 2 | Healthcare | 19.47% |
| 3 | Technology | 13.56% |
| 4 | Industrials | 12.48% |
| 5 | Consumer Discretionary | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
S
51
DELISTED
Sprint Corporation
S
| $27.4M | 0.74% |
+6,019,500
| New | +$27.4M |
|
52
D.R. Horton
DHI
$51.3B
| $26.7M | 0.72% |
+976,000
| New | +$26.7M |
|
53
Johnson & Johnson
JNJ
$429B
| $26.5M | 0.72% |
+272,400
| New | +$26.5M |
|
|
BGC
54
DELISTED
General Cable Corporation
BGC
| $24.7M | 0.66% |
+1,250,000
| New | +$24.7M |
|
55
Fluor
FLR
$6.93B
| $24.6M | 0.66% |
+463,500
| New | +$24.6M |
|
56
Biogen
BIIB
$20.8B
| $23.9M | 0.64% |
+59,180
| New | +$23.9M |
|
57
ON Semiconductor
ON
$19.5B
| $23.5M | 0.63% |
+2,009,000
| New | +$23.5M |
|
|
CELG
58
DELISTED
Celgene Corp
CELG
| $23.3M | 0.63% |
+201,600
| New | +$23.3M |
|
59
Micron Technology
MU
$133B
| $17.5M | 0.47% |
+931,300
| New | +$17.5M |
|
|
AGN
60
DELISTED
Allergan plc
AGN
| $17.4M | 0.47% |
+57,500
| New | +$17.4M |
|
|
BHI
61
DELISTED
Baker Hughes
BHI
| $17.2M | 0.46% |
+278,100
| New | +$17.2M |
|
62
Amgen
AMGN
$153B
| $16.8M | 0.45% |
+109,600
| New | +$16.8M |
|
|
AET
63
DELISTED
Aetna Inc
AET
| $16.1M | 0.43% |
+126,500
| New | +$16.1M |
|
64
Thermo Fisher Scientific
TMO
$183B
| $15.2M | 0.41% |
+117,000
| New | +$15.2M |
|
65
Wells Fargo
WFC
$258B
| $15.1M | 0.41% |
+269,270
| New | +$15.1M |
|
66
Revvity
RVTY
$9.68B
| $14.1M | 0.38% |
+266,900
| New | +$14.1M |
|
67
MasTec
MTZ
$14.2B
| $13.4M | 0.36% |
+671,900
| New | +$13.4M |
|
68
Centene
CNC
$14.8B
| $13.3M | 0.36% |
+164,800
| New | +$13.3M |
|
69
Incyte
INCY
$17B
| $12.8M | 0.34% |
+122,500
| New | +$12.8M |
|
|
TTM
70
DELISTED
Tata Motors Limited
TTM
| $12.7M | 0.34% |
+367,086
| New | +$12.7M |
|
71
Alphabet (Google) Class C
GOOG
$2.79T
| $12.3M | 0.33% |
+23,555
| New | +$12.3M |
|
72
UnitedHealth
UNH
$279B
| $12M | 0.32% |
+98,500
| New | +$12M |
|
73
Ionis Pharmaceuticals
IONS
$9.64B
| $11.6M | 0.31% |
+200,700
| New | +$11.6M |
|
74
Perrigo
PRGO
$3.21B
| $11.2M | 0.3% |
+60,500
| New | +$11.2M |
|
75
Regeneron Pharmaceuticals
REGN
$59.8B
| $10.2M | 0.27% |
+20,000
| New | +$10.2M |
|